Xtx Topco LTD Athenex, Inc. Transaction History

Xtx Topco LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.79 - $1.59 $27,217 - $54,780	-34,453 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.36 - $2.94 $46,856 - $101,291	34,453 New	34,453 $47,000
Q2 2021 Aug 12, 2021	SELL	$3.71 - $5.13 $67,685 - $93,591	-18,244 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$4.08 - $14.75 $74,435 - $269,099	18,244 New	18,244 $78,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.